HealthStream prices public offering of 3,250,000 shares of common stock

HealthStream, Inc. (the "Company") (NASDAQ: HSTM), announced today that it has priced a public offering of 3,250,000 shares of its common stock, consisting of 3,100,000 shares to be sold by the Company and 150,000 shares to be sold by certain selling shareholders at a price of $16.25 per share. William Blair & Company, L.L.C. is serving as the sole book-running manager of the public offering, and Avondale Partners, LLC and Craig-Hallum Capital Group, LLC are serving as co-managers of the public offering. The Company granted the underwriters a 30-day option to purchase up to an additional 487,500 shares at the public offering price, less the underwriting discount, to cover over-allotments, if any. Subject to customary conditions, the offering is expected to close on or about November 23, 2011.

The net proceeds to the Company of the public offering after deducting underwriting discounts and commissions and estimated expenses are expected to be approximately $47.7 million (or approximately $55.2 million if the underwriters exercise their over-allotment in full). The Company intends to use the net proceeds from the public offering for working capital and general corporate purposes and/or to acquire or invest in strategic businesses, products, or technologies. The Company will not receive any proceeds from the sale of shares made by the selling shareholders.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.